MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

491522

Report Date :

09.02.2018

 

 

IDENTIFICATION DETAILS

 

Name :

FERMENTA BIOTECH LIMITED

 

 

Registered Office :

A-1501, Thane One, DIL Complex, Ghodbunder Road, Majiwada, Thane (West) - 400610, Maharashtra

Tel. No.:

91-22-67980888 / 67980800

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

11.07.1986

 

 

Com. Reg. No.:

11-134021

 

 

Capital Investment / Paid-up Capital :

INR 177.045 Million

 

 

CIN No.:

[Company Identification No.]

U99999MH1986PLC134021

 

 

IEC No.:

2288003359

 

 

GSTIN:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACF2503N

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is engaged in the business of manufacturing and marketing of chemicals, bulk drugs enzymes, pharmaceutical formulations and environmental solution products. (Registered activity)

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Status :

Good 

 

 

Payment Behaviour :

Regular 

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of “DIL Limited” and it was incorporated on 11th July 1986. It is manufacturer and supplier of vitamin d3, enzymes, lipase and bio-enzymes for environmental solutions waste water management and lake and pond bioremediation.

 

As per financials of March 2017, the company has registered a growth of 8.25% in its revenue as compared to previous year’s revenue and has reported good profitability margin of 6.21% under review.

 

Rating takes into consideration the company’s established track record of business operations marked by sound net worth base along with strong debt coverage indicators and decent liquidity position.

 

Rating also takes into account the strong financial and managerial support received from its parent company and leadership position in the small, but growing market of Vitamin D3.

 

Further, the company has reported earnings per share of INR 5.44 against its face value of INR 10.

 

However, rating strengths is partially offset by the company’s exposure to intense competition in the active pharmaceutical ingredients and pharmaceutical contact manufacturing segments along with the vulnerability of its operating profitability to fluctuations in global Vitamin D3 prices and foreign exchange rates.

 

Payment terms are seems to be regular.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Rating = BBB-

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

12.12.2017

 

Rating Agency Name

CRISIL

Rating

Short Term Rating = A3+

Rating Explanation

Moderate degree of safety and higher credit risk.

Date

12.12.2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 09.02.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DENIED

 

Management Non-Cooperative (Tel No.: 91-22-67980888 / 67980800)

 

LOCATIONS

 

Registered Office :

A-1501, Thane One, DIL Complex, Ghodbunder Road, Majiwada, Thane (West) - 400610, Maharashtra, India

Tel. No.:

91-22-67980888 / 67980800

Fax No.:

91-22-67980999/ 67980899

E-Mail :

fermenta@fermentabiotech.com

info@fermentabiotech.com

Website :

www.fermentabiotech.com

 

 

Factory 1 :

Village Takoli, P. O. Nagwain, District Mandi – 175121, Himachal Pradesh, India

Tel. No.:

91-1905-287246/ 48/ 49

Fax No.:

91-1905-287250

 

 

Factory 2 :

Plot No. Z109, B and C, Dahej SEZ, Village Dahej, Taluka - Vagara, Bharuch – 392130, Gujarat, India 

Tel. No.:

91-2641-291440/ 444

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Satish Varma Azad Nadimpally

Designation :

Managing Director

Address :

Flat No. 1104, Quiscent Heights, Mindspace Link Road, Malad (West), Mumbai - 400064, Maharashtra, India

Date of Birth/Age :

21.03.1970

Qualification:

Computer Science

Date of Appointment :

01.05.2010

PAN No.:

AAPPV6580K

DIN No.:

00003255

 

 

Name :

Mrs. Anupama  Datla Desai

Designation :

Whole-Time Director

Address :

A/802, Aditya Samarth, Ramdas Marg, Juhu Scheme, Mumbai – 400049,  Maharashtra, India

Date of Birth/Age :

12.06.1978

Qualification :

Post Graduate in Biotechnology Science Graduate from The Boston College

Date of Appointment :

01.04.2012

PAN No.:

AEFPD0595N

DIN No.:

00217027

 

 

Name :

Mr. Sanjay Ramakant Buch

Designation :

Director

Address :

7/31, Bandra Sona CHS. Complex, Krishna Chandra Marg, Bandra (West), Mumbai – 400050, Maharashtra, India

Date of Birth/Age :

26.09.1968

Qualification:

B A Hons Economics

Date of Appointment :

27.09.2010

PAN No.:

AAPPB5842A

Voter ID :

MT/08/036/099611

DIN No.:

00391436

 

 

Name :

Mr. Peter John Bains

Designation :

Director

Address :

Hutchins Barn, Forty Green Road, Knotty Green, HP9IXL, Beaconsfield, United Kingdom - 76152

Date of Birth/Age :

26.07.1957

Qualification:

BSc Combined Hons. Physiology/Zoology Sheffield University

Date of Appointment :

27.09.2010

DIN No.:

00430937

 

 

Name :

Mr. Krishna Vasantkumar Datla

Designation :

Director

Address :

42 – B, Dhananjay Presidency CHS JVPD Scheme, Juhu, Vile Parle, Mumbai-400049, Maharashtra, India

Date of Birth/Age :

17.12.1980

Qualification:

B com

Date of Appointment :

01.02.2002

PAN No.:

AEIPD5499Q

DIN No.:

00003247

 

 

Name :

Mr. Gopakumar Gopalan Nair

Designation :

Director

Address :

C – 002/003, Gokul Plaza Thakur Complex Kandivali (East), Mumbai – 400101, Maharashtra, India

Date of Birth/Age :

11.06.1941

Qualification:

PhD from National Chemical Laboratory (NCL), Diploma in Management and Patent Law and L.L.B.

Date of Appointment :

24.09.2014

PAN No.:

AAAPN9727H

DIN No.:

00092637

 

 

KEY EXECUTIVES

 

Name :

Mr. Varadvinayak Vijay Khambete

Designation :

Company Secretary

Address :

101, A-11, Happy Valley Homes Near Tukuji-Ni-Wadi, Manpada, Thane (West) - 400 607, Thane - 400607, Maharashtra, India

Date of Appointment :

27.02.2017

PAN No.:

BHHPK8180J

 

 

Name :

Mr. Prashant Prabhakar Nagre

Designation :

Chief Executive Officer

Address :

2102, Fiona, Hiranandani Estate, Ghodbunder Road, Thane (West) - 400607, Thane, 400607, Maharashtra, India

Date of Birth/Age :

21.06.1970

Qualification :

B. Pharma, Post Graduate Diploma in Foreign Trade, Post Graduate Diploma in International Trade, Masters in Management Science

Date of Appointment :

12.09.2013

PAN:

AAKPN9407A

 

 

Name :

Mr. Amol Narayan Lone

Designation :

Chief Finance Officer

Address :

Flat No. 504, Building No. 16, Galaxy, Highland Re Dhokali Road, Thane (West), 400607, Thane - 400607, Maharashtra, India

Date of Appointment :

01.06.2017

PAN No.:

ACGPL7610R

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2017

 

Names of Shareholders

 

No. of Shares

Vijay Kumar Datla

 

12

Duraiswamy Gunasheela Rajan

 

12

O. Swaminatha Reddy

 

12

DIL Limited, India

 

12762464

V. R. Investment and Finance Private Limited, India

 

15000

D. Rajeshwari

 

90738

Govind Desai and Gunanath Govind Desai

 

2500

Govind Desai and Damodar Govind Desai

 

1000

Shaila G. Desai and Damodar Govind Desai

 

1500

S. Krishnan *

 

10

S C Uniyal

 

10

Preeti Thakkar

 

8412

Dupen Laboratories Private Limited, India

 

100000

Kumar Subrmanian *

 

10

S Raman *

 

10

Prashant Kutty *

 

20

DVK Investments Private Limited, India

 

87024

K H Kashid *

 

10

Krishna Datla

 

10800

Satish Varma *

 

10

Allegro Corporate Finance Advisors Private Limited, India

 

789474

Fermenta Biotech Limited ESOP Trust, India **

 

488334

Srikant Sharma *

 

10

Evolvence India Life Science Fund LLC, Mauritius

 

3830072

Anupama Datla Desai

 

5400

Total

 

18192844

 

Note:

  • *Share held u/s, erstwhile 187C of the Companies Act, 1956 (no Section 89 of Companies Act, 2013) in favour of DIL Limited.
  • **Amount of INR 4.883 million recoverable from Fermenta Biotech Limited ESOP trust.

 

Equity Share Break up (Percentage of Total Equity)

 

As on 14.09.2017

 

Category

Percentage

Promoter (Individual/ Hindu Undivided Family – Indian)

0.06

Promoter (Bodies corporate)

70.15

Public/Other than promoters (Individual/ Hindu Undivided Family – Indian)

0.60

Public/Other than promoters (Bodies corporate)

26.50

Public/Other than promoters (Others - FBL ESOP Trust)

2.69

Total

100.00

 

 


 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the business of manufacturing and marketing of chemicals, bulk drugs enzymes, pharmaceutical formulations and environmental solution products.

 

 

Products :

Item Code No.

Product Description

29362940

Vitamin D3

35079069

Biocatalyst and Enzymes

29331100

Phenyramidol Hcl

30049032

Silicon dry powder

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

 

Bank Name

ICICI Bank Limited

Branch

ICICI Bank Tower, Near Chakli Circle, Old Padra Road, Vadodara-390007, Gujarat, India

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

  • Union Bank of India, Ghodbunder Road Branch, Solitaire Tower, Manpada, Ghodbunder Road, Mumbai – 400607, Maharashtra, India

 

 

Facilities :

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Rupee term loans from banks

59.630

32.593

Rupee term loans from others

0.951

3.011

Loans taken for fixed assets

0.065

0.730

 

 

 

Short-term borrowings

 

 

Loans repayable on demand from banks

299.416

268.971

Total

360.062

305.305

 

Auditors :

 

Name :

S R B C and Company LLP

Chartered Accountants

Address :

14th Floor, The Ruby, 29 Senapati Bapat Marg, Dadar (West), Mumbai-400028, Maharashtra, India.

PAN N Income-tax PAN of auditor or auditor's firm :

ACHFS9117R

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding company :

  • Dil Limited, India

 

 

Subsidiary company :

  • G I Biotech Private Limited, India
  • Fermenta Biotech (UK) Limited, United Kingdom

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

  • Dupen Laboratories Private Limited, India
  • Lacto-Cosmetics (Vapi) Private Limited, India

 

 

 

Other related party:

  • DVK Investments Private Limited (Holds 0.48%)

 

CAPITAL STRUCTURE

 

As on 14.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

19010000

Equity Shares

INR 10/- each

INR 190.100 Million

990000

Preference Shares

INR 10/- each

INR 9.900 Million

 

Total

 

INR 200.000 Million 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

18192844

Equity Shares

INR 10/- each

INR 181.928 Million

 

As on 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

19010000

Equity Shares

INR 10/- each

INR 190.100 Million

990000

Preference Shares

INR 10/- each

INR 9.900 Million

 

Total

 

INR 200.000 Million 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

18192844

Equity Shares

INR 10/- each

INR 181.928 Million

 

Less: Calls Unpaid by Others

 

INR 4.883 Million

 

 

 

 

 

Total

 

INR 177.045 Million

 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET (STANDALONE)

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

177.045

177.045

177.045

(b) Reserves and Surplus

826.991

728.062

609.170

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1004.036

905.107

786.215

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

60.646

36.334

52.447

(b) Deferred tax liabilities (Net)

27.248

39.953

31.613

(c) Other long-term liabilities

0.000

0.000

0.000

(d) long-term provisions

19.245

14.376

13.473

Total Non-current Liabilities (3)

107.139

90.663

97.533

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

336.302

284.721

272.102

(b) Trade payables

271.921

180.356

150.832

(c) Other current liabilities

67.614

97.695

74.713

(d) Short-term provisions

6.172

18.998

3.117

Total Current Liabilities (4)

682.009

581.770

500.764

 

 

 

 

TOTAL

1793.184

1577.540

1384.512

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

742.348

680.485

721.379

(ii) Intangible Assets

5.012

8.048

9.469

(iii) Tangible assets capital work-in-progress

27.646

53.337

4.787

(iv) Intangible assets under development

14.252

0.300

5.276

(b) Non-current Investments

18.662

18.662

18.662

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

35.802

35.701

15.465

(e) Other Non-current assets

0.000

0.070

0.168

Total Non-Current Assets

843.722

796.603

775.206

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

387.459

248.378

210.217

(c) Trade receivables

446.219

433.829

353.791

(d) Cash and bank balances

11.449

8.449

3.435

(e) Short-term loans and advances

56.211

53.812

40.506

(f) Other current assets

48.124

36.469

1.357

Total Current Assets

949.462

780.937

609.306

 

 

 

 

TOTAL

1793.184

1577.540

1384.512

 

 

PROFIT & LOSS ACCOUNT (STANDALONE)

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Revenue from operations

1592.251

1470.959

1292.542

 

Other Income

23.236

26.953

1.010

 

TOTAL                

1615.487

1497.912

1293.552

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

759.930

628.483

605.626

 

Purchases of Stock-in-Trade

2.221

16.011

8.200

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(78.944)

(5.306)

15.888

 

Employee benefit expense

225.936

203.628

174.797

 

CSR expenditure

0.829

0.190

0.696

 

Other expenses

479.169

383.016

355.128

 

Prior period items before tax

1.707

0.000

0.000

 

TOTAL

1390.848

1226.022

1160.335

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

224.639

271.890

133.217

 

 

 

 

 

Less

FINANCIAL EXPENSES

36.234

45.462

47.001

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION 

188.405

226.428

86.216

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

67.241

64.674

67.276

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

121.164

161.754

18.940

 

 

 

 

 

Less

TAX

22.235

42.862

15.680

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

98.929

118.892

3.260

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD 

537.846

418.954

416.870

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Transfer to General Reserve

0.000

0.000

1.176

 

Total

0.000

0.000

1.176

 

 

 

 

 

 

Balance Carried to the B/S

636.775

537.846

418.954

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

1193.967

1009.854

918.443

 

TOTAL EARNINGS

1193.967

1009.854

918.443

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

436.923

384.703

310.936

 

Components and Stores parts

6.410

1.470

0.796

 

Capital Goods

5.018

4.602

9.540

 

TOTAL IMPORTS

448.351

390.775

321.272

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

5.43

6.54

0.18

 

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

33.027

60.897

53.559

Net cash flows from (used in) operations

135.031

150.529

174.603

Net cash flows from (used in) operating activities

94.340

131.334

150.259

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

102.29

107.65

99.91

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

3.57

3.39

3.65

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

130.23

102.14

89.69

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.58

1.09

0.63

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.28

0.37

0.18

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.43

0.43

0.44

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.43

0.42

0.48

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.68

0.64

0.64

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.79

0.82

0.94

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

6.20

5.98

2.83

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

6.21

8.08

0.25

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

5.52

7.54

0.24

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

9.85

13.14

0.41

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.39

1.34

1.22

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.82

0.92

0.80

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.56

0.57

0.57

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

2.43

2.16

2.14

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.39

1.34

1.22

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

177.045

177.045

177.045

Reserves & Surplus

609.170

728.062

826.991

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

786.215

905.107

1004.036

 

 

 

 

Long-term borrowings

52.447

36.334

60.646

Short term borrowings

272.102

284.721

336.302

Current maturities of long-term debts

53.559

60.897

33.027

Total borrowings

378.108

381.952

429.975

Debt/Equity ratio

0.481

0.422

0.428

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1292.542

1470.959

1592.251

 

 

13.804

8.246

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1292.542

1470.959

1592.251

Profit/ (Loss)

3.260

118.892

98.929

 

0.25 %

8.08 %

6.21 %

 

 

 

ABRIDGED BALANCE SHEET – (CONSOLIDATED)

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

177.045

177.045

(b) Reserves & Surplus

 

820.926

725.101

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Minority interest

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

997.971

902.146

 

 

 

(3) Non-Current Liabilities

 

 

(a) long-term borrowings

 

60.646

36.334

(b) Deferred tax liabilities (Net)

 

27.311

40.025

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

19.245

14.376

Total Non-current Liabilities (3)

 

107.202

90.735

 

 

 

(4) Current Liabilities

 

 

(a) Short term borrowings

 

336.302

284.721

(b) Trade payables

 

272.036

180.611

(c) Other current liabilities

 

67.526

97.607

(d) Short-term provisions

 

6.172

18.998

Total Current Liabilities (4)

 

682.036

581.937

 

 

 

TOTAL

 

1787.209

1574.848

 

 

 

II.          ASSETS

 

 

(1) Non-current assets

 

 

(a) Fixed Assets

 

 

(i) Tangible assets

 

743.566

681.937

(ii) Intangible Assets

 

13.104

18.268

(iii) Capital work-in-progress

 

27.646

53.337

(iv) Intangible assets under development

 

14.252

0.300

(b) Non-current Investments

 

0.200

0.200

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

35.176

35.075

(e) Other Non-current assets

 

0.000

0.070

Total Non-Current Assets

 

833.944

789.187

 

 

 

(2) Current assets

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

387.459

248.378

(c) Trade receivables

 

446.261

433.829

(d) Cash and cash equivalents

 

15.146

13.108

(e) Short-term loans and advances

 

56.275

53.877

(f) Other current assets

 

48.124

36.469

Total Current Assets

 

953.265

785.661

 

 

 

TOTAL

 

1787.209

1574.848

 

 

PROFIT & LOSS ACCOUNT– (CONSOLIDATED)

 

 

PARTICULARS

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Income

 

1592.251

1470.959

 

Other Income

 

23.236

27.067

 

TOTAL

 

1615.487

1498.026

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

759.930

628.483

 

Purchases of Stock-in-Trade

 

2.221

16.011

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(78.944)

(5.306)

 

Employee benefit expense

 

225.936

203.628

 

CSR expenditure

 

0.829

0.190

 

Other expenses

 

479.949

383.187

 

Prior period items before tax

 

1.707

0.000

 

TOTAL

 

1391.628

1226.193

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

223.859

271.833

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

36.234

45.462

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

187.625

226.371

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

69.603

65.440

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

118.022

160.931

 

 

 

 

 

Less

TAX

 

22.227

42.856

 

 

 

 

 

 

TOTAL PROFIT (LOSS) FOR PERIOD FROM CONTINUING OPERATIONS

 

95.795

118.076

 

 

 

 

 

Add

Minority Interest

 

0.030

0.036

 

 

 

 

 

 

TOTAL PROFIT (LOSS) FOR PERIOD

 

95.825

118.112

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

5.27

6.49

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

Yes

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

BACKGROUND:

 

The Company is a public company domiciled in India and incorporated under the Companies Act, 1956. The Company is engaged in the business of manufacturing and marketing of chemicals, bulk drugs enzymes, pharmaceutical formulations and environmental solution products. The Company caters to both domestic and international markets.

 

RESULTS FROM OPERATIONS

 

In financial year 2016-17 ('FY 2016-17'), Company's Revenue on a standalone basis increased to INR 1615.487 million compared to INR 1497.912 million in the previous year i. e. financial year 2015-16 ('FY 2015-16').Profit before tax for FY 2016-17 was INR 121.164 million compared to 161.754 million for FY 2015-16.Profit after tax was INR 98.929 million for FY 2016-17 compared to INR 118.892 million for FY 2015-16.

 

RESEARCH AND DEVELOPMENT EXPENDITURE

 

During the year research and development expenditure of INR 50.774 Million (2016 - INR 36.666 Million) (excluding interest and depreciation) has been charged to the statement of profit and loss. The capital expenditure in the current year on research and development amounts to INR 19.565 Million (2016 - INR 0.322 Million ).

 

UNSECURED LOAN

 

Particular

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Short-term borrowings

 

 

Loans and advances from related parties

0.000

15.750

Loans repayable on demand from banks

36.886

0.000

Total

36.886

15.750

 

 

INDEX OF CHARGES:

 

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G53339065

100122504

ICICI BANK LIMITED

12/04/2017

-

-

2800000.0

ICICI BANK TOWER, NEAR CHAKLI CIRCLE,OLD PADRA ROAD VADODARA-390007, GUJARAT,INDIA

2

C71207880

10604514

UNION BANK OF INDIA

03/11/2015

-

-

80000000.0

GHODBUNDER ROAD BRANCH, SOLITAIRE TOWER,MANPADA,GHODBUNDER ROAD,MUMBAI-400607, MAHARASHTRA, INDIA

3

C71203376

10604505

UNION BANK OF INDIA

03/11/2015

-

-

30000000.0

GHODBUNDER ROAD BRANCH, SOLITAIRE TOWER,MANPADA,GHODBUNDER ROAD,MUMBAI-400607, MAHARASHTRA, INDIA

4

C15738917

10514062

SIEMENS FINANCIAL SERVICES PRIVATE LIMITED

17/07/2014

-

-

9000000.0

130, PANDURANG BUDHKAR MARG,WORLI MUMBAI-400018, MAHARASHTRA, INDIA

5

B45355302

10369623

UNION BANK OF INDIA

18/07/2012

-

-

20000000.0

GHODBUNDER ROAD BRANCH, SOLITAIRE TOWER,MANPADA,GHODBUNDER ROAD,MUMBAI-400607, MAHARASHTRA, INDIA

6

B56909914

10373704

SIEMENS FINANCIAL SERVICES PRIVATE LIMITED

16/07/2012

-

-

35000000.0

130, PANDURANG BUDHKAR MARG,WORLI MUMBAI-400018, MAHARASHTRA, INDIA

7

G55543151

10311976

UNION BANK OF INDIA

18/10/2011

12/09/2017

-

390000000.0

GHODBUNDER ROAD BRANCH, SOLITAIRE TOWER,MANPADA,GHODBUNDER ROAD,MUMBAI-400607, MAHARASHTRA, INDIA

8

C03406105

10311912

UNION BANK OF INDIA Ghodbunder Road Branch,

22/09/2011

28/03/2014

-

60000000.0

GHODBUNDER ROAD BRANCH, SOLITAIRE TOWER,MANPADA,GHODBUNDER ROAD, MUMBAI-400607, MAHARASHTRA, INDIA

9

G54081773

10311913

UNION BANK OF INDIA

22/09/2011

28/08/2017

-

50000000.0

GHODBUNDER ROAD BRANCH, SOLITAIRE TOWER,MANPADA,GHODBUNDER ROAD,MUMBAI-400607, MAHARASHTRA, INDIA

10

G52783529

10330267

UNION BANK OF INDIA

19/05/2011

18/08/2017

-

529500000.0

GHODBUNDER ROAD BRANCH, SOLITAIRE TOWER,MANPADA,GHODBUNDER ROAD,MUMBAI-400607, MAHARASHTRA, INDIA

 

CONTINGENT LIABILITIES:

 

(INR in million)

PARTICULARS

31.03.2017

31.03.2016

Claims against company not acknowledged as debt

9.426

6.299

 


 

FIXED ASSETS

 

  • Land
  • Buildings
  • Factory building
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Motor vehicles

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.61

UK Pound

1

INR 90.17

Euro

1

INR 78.95

 

 

INFORMATION DETAILS

 

Information Gathered by :

SHA

 

 

Analysis Done by :

VIV

 

 

Report Prepared by :

RKI


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.